MedPath

Exercise intervention to prevent falls, enhance mobility and increase physical activity in community dwellers after stroke: a randomised controlled trial

Completed
Conditions
Individuals after stroke residing in the community
Stroke - Haemorrhagic
Stroke - Ischaemic
Registration Number
ACTRN12606000479505
Lead Sponsor
SW Health
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
350
Inclusion Criteria

Suffered one or more strokes; Able to walk 10 m independently with or without an aid; able to gain medical clearance to participate; able to give informed consent.

Exclusion Criteria

Cognitive impairment (Mini-Mental State Examination (MMSE) score less than 24); Insufficient communication or english language skills to participate safely; medical condition precluding exercise.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Falls[Measured monthly for 12 month study period];10m walk speed[Measured at baseline and within a month of completing the 12 month study period];6 min walk distance[Measured at baseline and within one month of completing the 12 month study period]
Secondary Outcome Measures
NameTimeMethod
Falls risk factors[Measured at baseline and within 1 month of completing the 12 month study period.];Mobility[Measured at baseline and within 1 month of completing the 12 month study period.];Habitual physical activity[Measured at baseline and within 1 month of completing the 12 month study period.];Community participation[Measured at baseline and within 1 month of completing the 12 month study period.];Quality of life[Measured at baseline and within 1 month of completing the 12 month study period.];Muscle extensibility[Measured at baseline and within 1 month of completing the 12 month study period.];Upper limb function[Measured at baseline and within 1 month of completing the 12 month study period.];Cognition[Measured at baseline and within 1 month of completing the 12 month study period.]
© Copyright 2025. All Rights Reserved by MedPath